[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"node-by-slug-\u002Fen\u002Finsights\u002Fwill-the-next-biotech-breakthrough-be-digital-before-its-biological-en":3,"related-content-view-26789-en":363},["Reactive",4],{"entity":5,"errors":-1},{"__typename":6,"status":7,"metatag":8,"id":202,"path":203,"hideNavigation":204,"title":205,"translations":206,"sharedHeaderRefMedia":214,"sharedTeaserTitle":13,"sharedTeaserText":240,"sharedTeaserRefMedia":242,"sharedParagraphs":244,"sharedTaxrefIndustries":328,"sharedTaxrefExpertises":332,"sharedIntroText":336,"sharedCtaLink":204,"sharedDate":338,"sharedAuthor":340},"NodeInsight",true,[9,14,18,21,25,30,34,38,42,46,50,54,58,62,66,69,73,76,79,81,84,87,91,95,99,103,107,111,115,119,123,127,131,135,139,142,145,148,151,154,157,160,163,166,170,174,177,181,185,189,193,196,200],{"tag":10,"attributes":11},"meta",{"name":12,"content":13},"title","Will digital come before biology in biotech’s next leap?",{"tag":10,"attributes":15},{"name":16,"content":17},"description","Read the conversation between David Elliman and Bibi Ephraim, Head of Digital Sciences at Genentech, about how AI is redefining the biotech landscape.",{"tag":10,"attributes":19},{"name":20,"content":17},"abstract",{"tag":10,"attributes":22},{"name":23,"content":24},"icbm","51.525772, -0.082716",{"tag":26,"attributes":27},"link",{"rel":28,"href":29},"shortlink","https:\u002F\u002Fcms.zuehlke.com\u002Fapi\u002Fgraphql",{"tag":26,"attributes":31},{"rel":32,"href":33},"canonical","https:\u002F\u002Fcms.zuehlke.com\u002Fen\u002Finsights\u002Fwill-the-next-biotech-breakthrough-be-digital-before-its-biological",{"tag":10,"attributes":35},{"name":36,"content":37},"robots","index, follow",{"tag":26,"attributes":39},{"rel":40,"href":41},"image_src","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Fmax_1300x1300\u002Fpublic\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png?itok=xHqc5Alv,https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":43},{"name":44,"content":45},"referrer","unsafe-url",{"tag":10,"attributes":47},{"name":48,"content":49},"rights","Copyright ©2026 | Zühlke Engineering AG | All rights reserved.",{"tag":10,"attributes":51},{"property":52,"content":53},"og:site_name","Zühlke Engineering AG",{"tag":10,"attributes":55},{"property":56,"content":57},"og:type","website",{"tag":10,"attributes":59},{"property":60,"content":61},"og:url","https:\u002F\u002Fwww.zuehlke.com\u002Fen\u002Finsights\u002Fwill-the-next-biotech-breakthrough-be-digital-before-its-biological",{"tag":10,"attributes":63},{"property":64,"content":65},"og:title","Will digital come before biology in biotech’s next leap? – Zühlke",{"tag":10,"attributes":67},{"property":68,"content":17},"og:description",{"tag":10,"attributes":70},{"property":71,"content":72},"og:image","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Fmax_1300x1300\u002Fpublic\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png?itok=xHqc5Alv",{"tag":10,"attributes":74},{"property":71,"content":75},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":77},{"property":78,"content":72},"og:image:url",{"tag":10,"attributes":80},{"property":78,"content":75},{"tag":10,"attributes":82},{"property":83,"content":72},"og:image:secure_url",{"tag":10,"attributes":85},{"property":83,"content":86},"https:\u002F\u002Fwww.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":88},{"property":89,"content":90},"og:updated_time","2026-05-06",{"tag":10,"attributes":92},{"property":93,"content":94},"og:image:alt","image",{"tag":10,"attributes":96},{"property":97,"content":98},"place:location:latitude","46.947944",{"tag":10,"attributes":100},{"property":101,"content":102},"place:location:longitude","7.438014",{"tag":10,"attributes":104},{"property":105,"content":106},"og:street_address","80 Great Eastern Street",{"tag":10,"attributes":108},{"property":109,"content":110},"og:locality","London",{"tag":10,"attributes":112},{"property":113,"content":114},"og:region","England",{"tag":10,"attributes":116},{"property":117,"content":118},"og:postal_code","EC2A 3JL",{"tag":10,"attributes":120},{"property":121,"content":122},"og:country_name","United Kingdom",{"tag":10,"attributes":124},{"property":125,"content":126},"og:email","london@zuhlke.com",{"tag":10,"attributes":128},{"property":129,"content":130},"og:phone_number","+44 20 7113 5000",{"tag":10,"attributes":132},{"property":133,"content":134},"og:locale","en_CH",{"tag":10,"attributes":136},{"property":137,"content":138},"og:locale:alternate","de_CH",{"tag":10,"attributes":140},{"property":137,"content":141},"de_DE",{"tag":10,"attributes":143},{"property":137,"content":144},"en_DE",{"tag":10,"attributes":146},{"property":137,"content":147},"en_AT",{"tag":10,"attributes":149},{"property":137,"content":150},"de_AT",{"tag":10,"attributes":152},{"property":137,"content":153},"en_HK",{"tag":10,"attributes":155},{"property":137,"content":156},"en_SR",{"tag":10,"attributes":158},{"property":137,"content":159},"en_BG",{"tag":10,"attributes":161},{"property":137,"content":162},"en_SG",{"tag":10,"attributes":164},{"property":137,"content":165},"en_GB",{"tag":10,"attributes":167},{"property":168,"content":169},"article:publisher","https:\u002F\u002Fwww.facebook.com\u002Fzuehlke.group",{"tag":10,"attributes":171},{"property":172,"content":173},"article:published_time","2025-11-03",{"tag":10,"attributes":175},{"property":176,"content":90},"article:modified_time",{"tag":10,"attributes":178},{"name":179,"content":180},"twitter:card","summary_large_image",{"tag":10,"attributes":182},{"name":183,"content":184},"twitter:site","@zuehlke_group",{"tag":10,"attributes":186},{"name":187,"content":188},"twitter:site:id","247189965",{"tag":10,"attributes":190},{"name":191,"content":192},"twitter:image","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Fmax_1300x1300\u002Fpublic\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png?itok=xHqc5Alv,https:\u002F\u002Fwww.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fzuhlke_innovation_social.jpg",{"tag":10,"attributes":194},{"name":195,"content":94},"twitter:image:alt",{"tag":10,"attributes":197},{"name":198,"content":199},"google-site-verification","VEzolc1Vxy1KyRIlIqUSmVS7fqP_3_ZeBqPRby4g2mE",{"tag":201},"script","26789","\u002Fen\u002Finsights\u002Fwill-the-next-biotech-breakthrough-be-digital-before-its-biological",null,"Will the next biotech breakthrough be digital before it’s biological?",[207,210],{"path":203,"langcode":208},{"id":209},"en",{"path":211,"langcode":212},"\u002Fde\u002Finsights\u002Fist-der-naechste-biotech-durchbruch-digital-bevor-er-biologisch-ist",{"id":213},"de",{"id":215,"sharedMediaLegend":204,"mediaImage":216,"name":239},"172502",{"url":217,"width":218,"height":219,"alt":220,"title":204,"size":221,"mime":222,"variations":204,"headerMinimalVariations":223},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png",1280,720,"A promotional graphic for the podcast “Tech Tomorrow with David Elliman.” On the left, there’s a portrait of a man wearing glasses and a maroon academic-style gown with a white shirt and matching tie. A label below the image reads “Bibi Ephraim.” The background features a dynamic blue and purple gradient design with abstract wave-like patterns.",2052664,"image\u002Fpng",[224,229,230,235,238],{"name":225,"url":226,"width":227,"height":228},"FOCAL_POINT32_SMALL","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png.webp?itok=Hne72IDN",800,533,{"name":225,"url":226,"width":227,"height":228},{"name":231,"url":232,"width":233,"height":234},"FOCAL_POINT169_MEDIUM","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_16_9_medium\u002Fpublic\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png.webp?itok=5ZA67RpB",1200,675,{"name":236,"url":237,"width":218,"height":219},"FOCAL_POINT169_LARGE","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_16_9_large\u002Fpublic\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png.webp?itok=C0xjLL3K",{"name":236,"url":237,"width":218,"height":219},"Thumbnail_Episode_4_Bibi_Ephraim.png",{"processed":241},"\u003Cp>Read the conversation between David Elliman and Bibi Ephraim, Head of Digital Sciences at Genentech, about how AI is redefining the biotech landscape.\u003C\u002Fp>",{"id":215,"sharedMediaLegend":204,"mediaImage":243,"name":239},{"url":217,"width":218,"height":219,"alt":220,"title":204,"size":221,"mime":222,"variations":204},[245,252,259,264,270,280,284,291,296,301],{"__typename":246,"id":247,"pgEmbededCode":248,"fullWidth":251,"edgeToEdge":251},"ParagraphPgCustomCode","33367",{"value":249,"processed":249,"format":250},"\u003Ciframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless=\"\" src=\"https:\u002F\u002Fshare.transistor.fm\u002Fe\u002Fe8613575\">\u003C\u002Fiframe>","custom_code",false,{"__typename":253,"id":254,"ctaLink":204,"pgSharedText":255,"pgSharedTitle":204,"pgSharedCtaLink":204},"ParagraphPgText","33361",{"value":256,"processed":257,"format":258},"\u003Cp>The biotech industry is at a tipping point where algorithms could drive the next generation of medical breakthroughs. As AI reshapes how we discover and develop treatments, the line between digital and biological innovation is blurring. But how far can technology go before we lose the 'bio' in biotechnology?\u003C\u002Fp>\u003Cp>In this episode of the \u003Ca href=\"\u002Fnode\u002F26709\" data-entity-type=\"node\" title=\"Explore all episodes of the Tech Tomorrow podcast\" data-entity-uuid=\"94f2836b-1d26-43d8-8630-29aaa98f52dc\" data-entity-substitution=\"canonical\">Tech Tomorrow podcast\u003C\u002Fa>, David Elliman, Zühlke’s Chief of Software Engineering, speaks with \u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fbibiephraim\" data-entity-type=\"external\" target=\"_blank\" title=\"Explore all episodes of the Tech Tomorrow podcast\">Bibi Ephraim\u003C\u002Fa>, Head of Digital Sciences at \u003Ca href=\"https:\u002F\u002Fwww.gene.com\u002F\" data-entity-type=\"external\" target=\"_blank\" title=\"Explore all episodes of the Tech Tomorrow podcast\">Genentech\u003C\u002Fa>, about the digital revolution in biotech — and what it takes to turn data into discovery.\u003C\u002Fp>","\u003Cp>The biotech industry is at a tipping point where algorithms could drive the next generation of medical breakthroughs. As AI reshapes how we discover and develop treatments, the line between digital and biological innovation is blurring. But how far can technology go before we lose the 'bio' in biotechnology?\u003C\u002Fp>\u003Cp>In this episode of the \u003Ca href=\"\u002Fen\u002Finsights\u002Ftech-tomorrow-podcast\" data-entity-type=\"node\" title=\"Explore all episodes of the Tech Tomorrow podcast\" data-entity-uuid=\"94f2836b-1d26-43d8-8630-29aaa98f52dc\" data-entity-substitution=\"canonical\">Tech Tomorrow podcast\u003C\u002Fa>, David Elliman, Zühlke’s Chief of Software Engineering, speaks with \u003Ca href=\"https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Fbibiephraim\" data-entity-type=\"external\" target=\"_blank\" title=\"Explore all episodes of the Tech Tomorrow podcast\">Bibi Ephraim\u003C\u002Fa>, Head of Digital Sciences at \u003Ca href=\"https:\u002F\u002Fwww.gene.com\u002F\" data-entity-type=\"external\" target=\"_blank\" title=\"Explore all episodes of the Tech Tomorrow podcast\">Genentech\u003C\u002Fa>, about the digital revolution in biotech — and what it takes to turn data into discovery.\u003C\u002Fp>","full_html",{"__typename":253,"id":260,"ctaLink":204,"pgSharedText":261,"pgSharedTitle":263,"pgSharedCtaLink":204},"33362",{"value":262,"processed":262,"format":258},"\u003Cp>Bibi Ephraim is the Head of Digital Sciences at Genentech, where he leads the convergence of biology, data and machine learning in biopharmaceutical R&D. With a career rooted in engineering and biotech, Bibi has spearheaded initiatives that transform laboratory workflows into digital platforms, from applying convolutional-neural-networks to cell-line image monitoring, to embedding machine-learning models into ultrafiltration\u002Fdiafiltration process control.\u003C\u002Fp>\u003Cp>Bibi Ephraim brings a rare dual perspective: fluency in biotechnology operations and deep experience in digital systems.\u003C\u002Fp>","Meet the guest: Bibi Ephraim",{"__typename":253,"id":265,"ctaLink":204,"pgSharedText":266,"pgSharedTitle":269,"pgSharedCtaLink":204},"33363",{"value":267,"processed":268,"format":258},"\u003Ch3>The Data foundation every breakthrough needs\u003C\u002Fh3>\u003Cp>'One of the biggest mistakes executives make is delegating data to IT,' says Bibi Ephraim. 'It needs to be treated as part of the business. Data creates value, and building a culture around it is key.'\u003C\u002Fp>\u003Cp>AI is already accelerating drug discovery, optimising clinical trials, and enabling precision medicine. But without clean, connected, and governed data foundations, progress stalls. Poor-quality data can derail timelines, inflate costs, and even force drug recalls. According to Gartner, organisations lose an average of $12.9 million a year due to bad data; a figure Bibi Ephraim calls 'conservative'.\u003C\u002Fp>\u003Cp>The takeaway? Before AI can transform biotech, data must stop being an afterthought. 'Executives need to champion \u003Ca href=\"\u002Fnode\u002F26549\" target=\"_blank\" title=\"Discover how Global Research Platforms partnered with Zühlke to build a data sharing and research collaboration platform for the Alzheimer's research\" data-entity-type=\"node\" data-entity-uuid=\"7a221cca-1668-4a05-83e4-46d7bf483a91\" data-entity-substitution=\"canonical\">data as a product\u003C\u002Fa>,' he argues, 'not just an input.'\u003C\u002Fp>\u003Ch3>Collaboration over competition\u003C\u002Fh3>\u003Cp>AI thrives on diversity: not just in datasets, but in ideas. The pandemic showed what’s possible when organisations collaborate openly, sharing data to accelerate vaccine development. Yet, as Ephraim points out, 'Scientists are trained to be independent, even competitive. But true innovation now depends on collaboration.'\u003C\u002Fp>\u003Cp>David Elliman calls this '\u003Ca href=\"\u002Fnode\u002F26278\" target=\"_blank\" title=\"Discover how Global Research Platforms partnered with Zühlke to build a data sharing and research collaboration platform for the Alzheimer's research\" data-entity-type=\"node\" data-entity-uuid=\"1d690269-03bd-49b3-be5a-4b4fe0031669\" data-entity-substitution=\"canonical\">pre-competitive collaboration\u003C\u002Fa>', meaning that competitors unite to solve shared challenges. 'Some problems are everyone’s problems,' he says. 'When engineers from different companies work on them, they bring unique perspectives and create more robust solutions than any one organisation could alone.'\u003C\u002Fp>\u003Cp>To make this work, leaders must define clear boundaries, defining what’s shared and what stays proprietary, and dedicate real investment to shared innovation. Collaboration isn’t a side project anymore; it’s strategic infrastructure.\u003C\u002Fp>\u003Ch3>From wet labs to digital twins\u003C\u002Fh3>\u003Cp>The transformation isn’t theoretical. AI is already redefining the lab itself.\u003C\u002Fp>\u003Cp>\u003Ca href=\"\u002Fnode\u002F6883\" target=\"_blank\" title=\"How a digital twin supported the COVID-19 response \" data-entity-type=\"node\" data-entity-uuid=\"16ff61bd-cd3a-4063-b7e1-94f68336e896\" data-entity-substitution=\"canonical\">Digital twins\u003C\u002Fa> — virtual replicas of biological systems — are allowing scientists to run simulations before physical experiments begin. Instead of testing thousands of molecules in a lab, AI can predict which ones will work best, dramatically accelerating development.\u003C\u002Fp>","\u003Ch3>The Data foundation every breakthrough needs\u003C\u002Fh3>\u003Cp>'One of the biggest mistakes executives make is delegating data to IT,' says Bibi Ephraim. 'It needs to be treated as part of the business. Data creates value, and building a culture around it is key.'\u003C\u002Fp>\u003Cp>AI is already accelerating drug discovery, optimising clinical trials, and enabling precision medicine. But without clean, connected, and governed data foundations, progress stalls. Poor-quality data can derail timelines, inflate costs, and even force drug recalls. According to Gartner, organisations lose an average of $12.9 million a year due to bad data; a figure Bibi Ephraim calls 'conservative'.\u003C\u002Fp>\u003Cp>The takeaway? Before AI can transform biotech, data must stop being an afterthought. 'Executives need to champion \u003Ca href=\"\u002Fen\u002Finsights\u002Flab-automation-in-pharma\" target=\"_blank\" title=\"Discover how Global Research Platforms partnered with Zühlke to build a data sharing and research collaboration platform for the Alzheimer's research\" data-entity-type=\"node\" data-entity-uuid=\"7a221cca-1668-4a05-83e4-46d7bf483a91\" data-entity-substitution=\"canonical\">data as a product\u003C\u002Fa>,' he argues, 'not just an input.'\u003C\u002Fp>\u003Ch3>Collaboration over competition\u003C\u002Fh3>\u003Cp>AI thrives on diversity: not just in datasets, but in ideas. The pandemic showed what’s possible when organisations collaborate openly, sharing data to accelerate vaccine development. Yet, as Ephraim points out, 'Scientists are trained to be independent, even competitive. But true innovation now depends on collaboration.'\u003C\u002Fp>\u003Cp>David Elliman calls this '\u003Ca href=\"\u002Fen\u002Fcase-studies\u002Fglobal-research-platforms-and-zuhlke-are-fighting-alzheimers-disease\" target=\"_blank\" title=\"Discover how Global Research Platforms partnered with Zühlke to build a data sharing and research collaboration platform for the Alzheimer's research\" data-entity-type=\"node\" data-entity-uuid=\"1d690269-03bd-49b3-be5a-4b4fe0031669\" data-entity-substitution=\"canonical\">pre-competitive collaboration\u003C\u002Fa>', meaning that competitors unite to solve shared challenges. 'Some problems are everyone’s problems,' he says. 'When engineers from different companies work on them, they bring unique perspectives and create more robust solutions than any one organisation could alone.'\u003C\u002Fp>\u003Cp>To make this work, leaders must define clear boundaries, defining what’s shared and what stays proprietary, and dedicate real investment to shared innovation. Collaboration isn’t a side project anymore; it’s strategic infrastructure.\u003C\u002Fp>\u003Ch3>From wet labs to digital twins\u003C\u002Fh3>\u003Cp>The transformation isn’t theoretical. AI is already redefining the lab itself.\u003C\u002Fp>\u003Cp>\u003Ca href=\"\u002Fen\u002Finsights\u002Fdigital-twin-for-covid-19\" target=\"_blank\" title=\"How a digital twin supported the COVID-19 response \" data-entity-type=\"node\" data-entity-uuid=\"16ff61bd-cd3a-4063-b7e1-94f68336e896\" data-entity-substitution=\"canonical\">Digital twins\u003C\u002Fa> — virtual replicas of biological systems — are allowing scientists to run simulations before physical experiments begin. Instead of testing thousands of molecules in a lab, AI can predict which ones will work best, dramatically accelerating development.\u003C\u002Fp>","Key takeaways from the episode",{"__typename":271,"id":272,"eyebrow":204,"pgQuoteRefQuote":273,"hideImage":251,"hideFunctionAndCompany":251,"bigQuote":251},"ParagraphPgQuote","33368",[274],{"status":7,"id":275,"promote":251,"quotePersonDesc":276,"quotePersonName":277,"quoteText":278,"profileImage":204,"title":279},"26790","Head of Digital Sciences at Genentech","Bibi Ephraim","The core of the shift is the recognition that biology is now essentially a form of information technology. DNA is a code. Proteins are complex machines built from copes; disease is, essentially you can treat it as a software bug and a biological system.","Tech Tomorrow Podcast: Bibi Ephraim 1",{"__typename":253,"id":281,"ctaLink":204,"pgSharedText":282,"pgSharedTitle":204,"pgSharedCtaLink":204},"33364",{"value":283,"processed":283,"format":258},"\u003Cp>Generative AI takes this even further, designing entirely new molecules from scratch. The result? Faster, smarter drug discovery, and a feedback loop where digital models and lab experiments refine each other in real time.\u003C\u002Fp>\u003Ch3>The race to scale responsibly\u003C\u002Fh3>\u003Cp>The question isn’t whether biotech will go digital; it’s how fast. Bibi Ephraim predicts that companies who move quickly to integrate AI and build data maturity will become the clear winners. 'Scaling isn’t the problem,' he says. 'Timing is.'\u003C\u002Fp>",{"__typename":271,"id":285,"eyebrow":204,"pgQuoteRefQuote":286,"hideImage":251,"hideFunctionAndCompany":251,"bigQuote":251},"33369",[287],{"status":7,"id":288,"promote":251,"quotePersonDesc":276,"quotePersonName":277,"quoteText":289,"profileImage":204,"title":290},"26791","One of the most common mistakes that is being made by executives is to delegate data initiatives to solely their informatics or IT departments. It needs to be treated as part and parcel of the business. It needs to be understood that this is something that's going to create value and the establishment of single sources of truth.","Tech Tomorrow Podcast: Bibi Ephraim 2",{"__typename":253,"id":292,"ctaLink":204,"pgSharedText":293,"pgSharedTitle":204,"pgSharedCtaLink":204},"33365",{"value":294,"processed":295,"format":258},"\u003Cp>But with rapid progress comes responsibility. \u003Ca href=\"\u002Fnode\u002F1815\" title=\"Discover five principles for applying AI in Pharma and Life Science\" data-entity-type=\"node\" data-entity-uuid=\"e786ec16-bb01-4f34-9cc1-1455abf5ce66\" data-entity-substitution=\"canonical\" target=\"_blank\">Explainability\u003C\u002Fa> (understanding how AI reaches its conclusions) remains a major hurdle in healthcare. Trust, transparency, and regulation will define which innovations succeed.\u003C\u002Fp>\u003Cp>Still, Bibi Ephraim remains optimistic: 'Digital will lead the way. The biological will validate. Together, they’ll create a new paradigm.'\u003C\u002Fp>","\u003Cp>But with rapid progress comes responsibility. \u003Ca href=\"\u002Fen\u002Finsights\u002Ffive-principles-for-applying-ai-in-pharma-and-life-science\" title=\"Discover five principles for applying AI in Pharma and Life Science\" data-entity-type=\"node\" data-entity-uuid=\"e786ec16-bb01-4f34-9cc1-1455abf5ce66\" data-entity-substitution=\"canonical\" target=\"_blank\">Explainability\u003C\u002Fa> (understanding how AI reaches its conclusions) remains a major hurdle in healthcare. Trust, transparency, and regulation will define which innovations succeed.\u003C\u002Fp>\u003Cp>Still, Bibi Ephraim remains optimistic: 'Digital will lead the way. The biological will validate. Together, they’ll create a new paradigm.'\u003C\u002Fp>",{"__typename":253,"id":297,"ctaLink":204,"pgSharedText":298,"pgSharedTitle":300,"pgSharedCtaLink":204},"33366",{"value":299,"processed":299,"format":258},"\u003Cp>AI may never replace biology entirely, nor should it. But it’s already reshaping every stage of biotech innovation, from molecule modelling to patient outcomes. As David Elliman puts it, 'Digital enhances the biological. The two evolve together.'\u003C\u002Fp>\u003Cp>The future of biotech isn’t one of replacement, but of reinforcement, where digital intelligence accelerates human insight. The next breakthrough won’t just be biological. It will be born digital.\u003C\u002Fp>","The future is hybrid",{"__typename":302,"id":303,"title":304,"text":305,"pgCtaLink":306,"imageLayout":309,"media":310},"ParagraphPgTeaserBig","35030","Discover all Tech Tomorrow episodes","Tech Tomorrow is your front-row seat to the conversations redefining the future. Each episode explores one big question about data, AI, or emerging tech, giving leaders clear, focused answers they can trust.",{"title":307,"url":308,"internal":7},"Explore all episodes","\u002Fen\u002Finsights\u002Ftech-tomorrow-podcast","left",{"id":311,"sharedMediaLegend":204,"mediaImage":312,"name":327},"173199",{"url":313,"width":314,"height":314,"alt":315,"title":204,"size":316,"mime":222,"variations":204,"teaserVariations":317},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Ftech_tomorrow_teaser_blogs.png",1080,"Tech Tomorrow podcast thumbnail featuring host David Elliman smiling inside a circular frame on a purple and blue abstract background, with the text “Tech Tomorrow with David Elliman” displayed on the right.",3077352,[318,320,321,325,326],{"name":225,"url":319,"width":227,"height":228},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Ftech_tomorrow_teaser_blogs.png.webp?itok=_fFx-z4d",{"name":225,"url":319,"width":227,"height":228},{"name":322,"url":323,"width":314,"height":324},"FOCAL_POINT54_MEDIUM","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_5_4_medium\u002Fpublic\u002Fimages\u002Ftech_tomorrow_teaser_blogs.png.webp?itok=IjFixnwC",864,{"name":322,"url":323,"width":314,"height":324},{"name":322,"url":323,"width":314,"height":324},"tech_tomorrow_teaser_blogs.png",[329],{"id":330,"name":331},"12","Pharma",[333],{"id":334,"name":335},"110","AI",{"processed":337},"\u003Cp>In this episode of the Tech Tomorrow podcast, David Elliman speaks with Bibi Ephraim, Head of Digital Sciences at Genentech, about how artificial intelligence is redefining the biotech landscape.\u003C\u002Fp>\n",{"timestamp":339},1762257600,[341],{"status":7,"contactName":342,"contactProfession":343,"contactLinkedinUrl":344,"sharedEmail":347,"sharedRefMedia":348},"David Elliman","Global Chief of Software Engineering",{"title":345,"url":346,"internal":251},"","https:\u002F\u002Fwww.linkedin.com\u002Fin\u002Felliman\u002F","david.elliman@zuhlke.com",{"id":349,"sharedMediaLegend":204,"mediaImage":350,"name":362},"167342",{"url":351,"width":227,"height":227,"alt":342,"title":204,"size":352,"mime":353,"variations":204,"authorVariations":354},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fdavid-elliman_0.jpeg",100830,"image\u002Fjpeg",[355,358,359,360,361],{"name":356,"url":357,"width":227,"height":227},"FOCAL_POINT11_SMALL","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_1_1_small\u002Fpublic\u002Fimages\u002Fdavid-elliman_0.jpeg.webp?itok=KqGd6fb7",{"name":356,"url":357,"width":227,"height":227},{"name":356,"url":357,"width":227,"height":227},{"name":356,"url":357,"width":227,"height":227},{"name":356,"url":357,"width":227,"height":227},"david-elliman.jpeg",[364,395,420,449],{"id":365,"path":366,"sharedTeaserTitle":367,"sharedTeaserRefMedia":368,"sharedTaxrefIndustries":386,"sharedTaxrefExpertises":390},"25818","\u002Fen\u002Finsights\u002Ffrom-code-to-conversation-the-new-era-of-digital-interaction","Digital interaction: the role of LLMs in personalising experiences",{"id":369,"sharedMediaLegend":204,"mediaImage":370,"name":385},"169796",{"url":371,"width":372,"height":373,"alt":374,"title":204,"size":375,"mime":353,"variations":204,"relatedContentVariations":376},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Fai-touch-screen_1.jpg",1920,1617,"\"\"",333374,[377,379,380,383,384],{"name":225,"url":378,"width":227,"height":228},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Fai-touch-screen_1.jpg.webp?itok=ftqe8Ug0",{"name":225,"url":378,"width":227,"height":228},{"name":381,"url":382,"width":233,"height":227},"FOCAL_POINT32_MEDIUM","https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002Fai-touch-screen_1.jpg.webp?itok=UGyvSLba",{"name":381,"url":382,"width":233,"height":227},{"name":381,"url":382,"width":233,"height":227},"ai-touch-screen.jpg",[387],{"id":388,"name":389},"855","All industries",[391,392],{"id":334,"name":335},{"id":393,"name":394},"129","Experience design",{"id":396,"path":397,"sharedTeaserTitle":398,"sharedTeaserRefMedia":399,"sharedTaxrefIndustries":414,"sharedTaxrefExpertises":418},"26501","\u002Fen\u002Finsights\u002Fcomputer-vision-in-retail","Computer vision in retail: How AI-enabled video is giving retail stores a new set of eyes",{"id":400,"sharedMediaLegend":204,"mediaImage":401,"name":413},"171760",{"url":402,"width":218,"height":219,"alt":403,"title":204,"size":404,"mime":353,"variations":204,"relatedContentVariations":405},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002FDigital%20eye%20representing%20computer%20vision%20in%20retail.jpg","Digital eye representing computer vision in retail",172163,[406,408,409,411,412],{"name":225,"url":407,"width":227,"height":228},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002FDigital%20eye%20representing%20computer%20vision%20in%20retail.jpg.webp?itok=eueU9Zdp",{"name":225,"url":407,"width":227,"height":228},{"name":381,"url":410,"width":314,"height":219},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002FDigital%20eye%20representing%20computer%20vision%20in%20retail.jpg.webp?itok=uAMr89Ui",{"name":381,"url":410,"width":314,"height":219},{"name":381,"url":410,"width":314,"height":219},"Digital eye representing computer vision in retail.jpg",[415],{"id":416,"name":417},"9","Commerce & retail",[419],{"id":334,"name":335},{"id":421,"path":422,"sharedTeaserTitle":423,"sharedTeaserRefMedia":424,"sharedTaxrefIndustries":442,"sharedTaxrefExpertises":444},"348","\u002Fen\u002Finsights\u002Freclaiming-your-healthcare-data","Reclaiming your healthcare data",{"id":425,"sharedMediaLegend":204,"mediaImage":426,"name":441},"278",{"url":427,"width":428,"height":429,"alt":430,"title":204,"size":431,"mime":353,"variations":204,"relatedContentVariations":432},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fimages\u002Freclaiming_healthcare_data.jpg",693,520,"Healthcare data on iPad",180148,[433,436,437,439,440],{"name":225,"url":434,"width":428,"height":435},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_small\u002Fpublic\u002Fimages\u002Freclaiming_healthcare_data.jpg.webp?itok=rXgthDSh",462,{"name":225,"url":434,"width":428,"height":435},{"name":381,"url":438,"width":428,"height":435},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002Freclaiming_healthcare_data.jpg.webp?itok=BsCTECtr",{"name":381,"url":438,"width":428,"height":435},{"name":381,"url":438,"width":428,"height":435},"reclaiming_healthcare_data.jpg",[443],{"id":330,"name":331},[445,446],{"id":334,"name":335},{"id":447,"name":448},"19","Digital strategy",{"id":202,"path":203,"sharedTeaserTitle":13,"sharedTeaserRefMedia":450,"sharedTaxrefIndustries":459,"sharedTaxrefExpertises":461},{"id":215,"sharedMediaLegend":204,"mediaImage":451,"name":239},{"url":217,"width":218,"height":219,"alt":220,"title":204,"size":221,"mime":222,"variations":204,"relatedContentVariations":452},[453,454,455,457,458],{"name":225,"url":226,"width":227,"height":228},{"name":225,"url":226,"width":227,"height":228},{"name":381,"url":456,"width":314,"height":219},"https:\u002F\u002Fcms.zuehlke.com\u002Fsites\u002Fdefault\u002Ffiles\u002Fstyles\u002Ffocal_point_3_2_medium\u002Fpublic\u002Fimages\u002FThumbnail_Episode_4_Bibi_Ephraim.png.webp?itok=DH3u-OnL",{"name":381,"url":456,"width":314,"height":219},{"name":381,"url":456,"width":314,"height":219},[460],{"id":330,"name":331},[462],{"id":334,"name":335}]